Human Cd46-transgenic Mice in Studies Involving Replication-incompetent Adenoviral Type 35 Vectors.
From: Crucell Holland BV, Archimedesweg 4, 2333 CN Leiden, The Netherlands.
The Journal of general virology
- Publish Date: Feb 2006
- ISSN: 0022-1317
- Volume: 87
- Issue: Pt 2
- Pages: 255-65
- Medium: Print
- Language: English
- Citation (JAMA): Verhaagh Sandra, de Jong Esmeralda, Goudsmit Jaap, et al. Human Cd46-transgenic Mice in Studies Involving Replication-incompetent Adenoviral Type 35 Vectors.. J. Gen. Virol. Feb 2006;87:255-65
Abstract
Wild-type strains of mice do not express CD46, a high-affinity receptor for human group B adenoviruses including type 35. Therefore, studies performed to date in mice using replication-incompetent Ad35 (rAd35) vaccine carriers may underestimate potency or result in altered vector distribution. Here, it is reported that CD46 transgenic mice (MYII-strain) express CD46 in all major organs and that it functions as a receptor for rAd35 vectors. Similar to monkeys and humans, MYII mice highly express CD46 in their lungs and kidneys and demonstrate low expression in muscle. Upon intravenous administration, rAd35 vector genomes as well as expression are detected in lungs of MYII mice, in contrast to wild-type littermates. Expression was predominantly detected in lung epithelial cells. Upon intramuscular administration, the initial level of luciferase expression is higher in MYII mice as compared with wild-type littermates, in spite of the fact that CD46 expression is low in muscle of MYII mice. The higher level of expression in muscle of MYII mice results in prolonged gene expression as assessed by CCD camera imaging for luciferase activity. Finally, a significant dose-sparing effect in MYII mice as compared with wild-type littermates on anti-SIVgag CD8+ T-cell induction following intramuscular vaccination with an rA35.SIVgag vaccine was observed. This dose-sparing effect was also observed when reinfusing dendritic cells derived from MYII mice after exposure to rAd35.SIVgag vaccine as compared with rAd35.SIVgag exposed dendritic cells from wild-type littermates. It was concluded that MYII mice represent an interesting preclinical model to evaluate potency and safety of rAd35 vectors.
Mesh Headings (Keywords): Adenoviruses, Human, Animals, Antigens, CD46, Genetic Vectors, Humans, Mice, Mice, Transgenic, Virus Replication
Check for Full Text / PubMed Unique Identifier (PMID): 16432010
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.